Health Care & Life Sciences » Pharmaceuticals | Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
241.42 M
Public Float
-
Hikma Pharmaceuticals PLC
Stock Exchange London Stock Exchange
EPS
GBP0.88
Market Cap
GBP4.28 B
Shares Outstanding
241.42 M
Public Float
137.42 M

Profile

Address
1 New Burlington Place
London Greater London W1S 2HR
United Kingdom
Employees -
Website http://hikma.com
Updated 07/08/2019
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment offers selling of branded generics and in-licensed patented products.

Financials

View All
Created with Highcharts 5.0.14Hikma Pharmaceuticals PLCNet Income. Fiscal year is January-December. All values GBP Millions.1361361691691651651151156556552112112013201420152016201720180200400600800
Created with Highcharts 5.0.14Hikma Pharmaceuticals PLCSales/Revenue. Fiscal year is January-December. All values GBP Millions.8738739049049439431 4451 4451 5031 5031 5571 5572013201420152016201720180500100015002000

Said Samih Taleb Darwazah
Executive Chairman
Sigurdur Oli Olafsson
Chief Executive Officer & Director